Walleye Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.4M Buy
48,923
+5,052
+12% +$488K 0.01% 1822
2026
Q2
$3.43M Sell
43,871
-9,493
-18% -$647K 0.01% 1077
2026
Q1
$3.45M Buy
53,364
+8,696
+19% +$613K 0.01% 1043
2025
Q4
$3.01M Buy
44,668
+36,967
+480% +$2.49M 0.01% 1529
2025
Q3
$565K Buy
+7,701
New +$512K ﹤0.01% 2513
2025
Q2
– Sell
-1,682
Closed -$95.7K – 4702
2025
Q1
$107K Buy
+1,682
New +$97.7K ﹤0.01% 3587
2024
Q4
– Sell
-2,119
Closed -$121K – 5121
2024
Q3
$121K Sell
2,119
-185,241
-99% -$10.6M ﹤0.01% 4312
2024
Q2
$9.8M Buy
187,360
+72,754
+63% +$3.19M 0.02% 774
2024
Q1
$4.66M Buy
114,606
+21,793
+23% +$817K 0.01% 1345
2023
Q4
$3.43M Sell
92,813
-126,845
-58% -$4.78M 0.01% 1369
2023
Q3
$8.39M Buy
219,658
+215,852
+5,671% +$8.84M 0.02% 670
2023
Q2
$137K Buy
+3,806
New +$130K ﹤0.01% 3298
2022
Q3
– Sell
-11,372
Closed -$503K – 3355
2022
Q2
$500K Buy
+11,372
New +$492K 0.01% 1029
2022
Q1
– Sell
-8,663
Closed -$348K – 2405
2021
Q4
$348K Buy
+8,663
New +$323K 0.01% 1161
2019
Q4
– Sell
-16,520
Closed -$256K – 1980
2019
Q3
$256K Buy
16,520
+2,810
+20% +$46.3K 0.02% 1067
2019
Q2
$236K Buy
+13,710
New +$221K 0.03% 877

Other funds holding HALO

Walleye Capital's HALO Position: Q3 2026 in Review

Walleye Capital increased its Halozyme (HALO) stake by 12% in Q3 2026, buying an estimated $488K and bringing the position to 48,923 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #1822.

Walleye Capital first reported a position in HALO in Q2 2019 and has held it in 16 quarters since. The position peaked at $9.8M in Q2 2024. 772 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Walleye Capital held 48,923 shares of Halozyme worth $5.4M as of Q3 2026.
  • Walleye Capital bought 5,052 Halozyme shares in Q3 2026, an estimated $488K.
  • Halozyme made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1822 holding.
  • Walleye Capital first reported a position in Halozyme in Q2 2019 and has held it in 16 quarters since.
  • Walleye Capital's Halozyme position peaked at $9.8M in Q2 2024.
  • 772 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.